CHInese Medicine NeuroAid Efficacy on Stroke Recovery "CHIMES"


Phase 3 Results N/A

Summary of Purpose

CHIMES is a double blind, placebo controlled, randomized, multicenter study to test the hypothesis that NeuroAid is superior to placebo in reducing neurological deficit and improving functional outcome in patients with cerebral infarction of an intermediate range of severity.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 30 April 2014.

1 May 2007 5 Nov 2007 1 Aug 2012 1 Aug 2012 1 Apr 2014 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment